Correlation Between Neurocrine Biosciences and 651639AZ9
Specify exactly 2 symbols:
By analyzing existing cross correlation between Neurocrine Biosciences and NEM 26 15 JUL 32, you can compare the effects of market volatilities on Neurocrine Biosciences and 651639AZ9 and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neurocrine Biosciences with a short position of 651639AZ9. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neurocrine Biosciences and 651639AZ9.
Diversification Opportunities for Neurocrine Biosciences and 651639AZ9
-0.75 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Neurocrine and 651639AZ9 is -0.75. Overlapping area represents the amount of risk that can be diversified away by holding Neurocrine Biosciences and NEM 26 15 JUL 32 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NEM 26 15 and Neurocrine Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neurocrine Biosciences are associated (or correlated) with 651639AZ9. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NEM 26 15 has no effect on the direction of Neurocrine Biosciences i.e., Neurocrine Biosciences and 651639AZ9 go up and down completely randomly.
Pair Corralation between Neurocrine Biosciences and 651639AZ9
Given the investment horizon of 90 days Neurocrine Biosciences is expected to generate 0.46 times more return on investment than 651639AZ9. However, Neurocrine Biosciences is 2.17 times less risky than 651639AZ9. It trades about 0.25 of its potential returns per unit of risk. NEM 26 15 JUL 32 is currently generating about 0.07 per unit of risk. If you would invest 12,565 in Neurocrine Biosciences on September 23, 2024 and sell it today you would earn a total of 977.00 from holding Neurocrine Biosciences or generate 7.78% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Weak |
Accuracy | 95.45% |
Values | Daily Returns |
Neurocrine Biosciences vs. NEM 26 15 JUL 32
Performance |
Timeline |
Neurocrine Biosciences |
NEM 26 15 |
Neurocrine Biosciences and 651639AZ9 Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Neurocrine Biosciences and 651639AZ9
The main advantage of trading using opposite Neurocrine Biosciences and 651639AZ9 positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neurocrine Biosciences position performs unexpectedly, 651639AZ9 can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 651639AZ9 will offset losses from the drop in 651639AZ9's long position.Neurocrine Biosciences vs. Amphastar P | Neurocrine Biosciences vs. Collegium Pharmaceutical | Neurocrine Biosciences vs. Ironwood Pharmaceuticals | Neurocrine Biosciences vs. ANI Pharmaceuticals |
651639AZ9 vs. AEP TEX INC | 651639AZ9 vs. US BANK NATIONAL | 651639AZ9 vs. Republic Bancorp | 651639AZ9 vs. BYD Co Ltd |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Other Complementary Tools
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |